In vitro binding and receptor-mediated activity of terlipressin at vasopressin receptors V1 and V2
Khurram Jamil,1 Stephen Chris Pappas,2 Krishna R Devarakonda1 1Clinical Development, Mallinckrodt Pharmaceuticals, Bedminster, 2Orphan Therapeutics, LLC, Lebanon, NJ, USA Abstract: Terlipressin, a synthetic, systemic vasoconstrictor with selective activity at ­vasopressin-1 (V1) receptors, i...
Main Authors: | Jamil K, Pappas SC, Devarakonda KR |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-12-01
|
Series: | Journal of Experimental Pharmacology |
Subjects: | |
Online Access: | https://www.dovepress.com/in-vitro-binding-and-receptor-mediated-activity-of-terlipressin-at-vas-peer-reviewed-fulltext-article-JEP |
Similar Items
-
Pharmacokinetic and pharmacodynamic analyses of terlipressin in patients with hepatorenal syndrome
by: Xiaofeng Wang, et al.
Published: (2022-04-01) -
Terlipressin Induced Severe Hyponatremia
by: Martin Šíma, et al.
Published: (2016-01-01) -
Terlipressin-induced hyponatremic encephalopathy in a noncirrhotic patient
by: Yao-Kuang Wang, et al.
Published: (2013-12-01) -
Terlipressin for the Prevention and Treatment of Renal Decline in Hepatorenal Syndrome: A Drug Profile
by: Ahlam Ayyad, et al.
Published: (2023-09-01) -
Terlipressin in obstetric and gynecological practice: a case of a missed miscarriage in late pregnancy complicated by bleeding. Case report
by: Vitaly B. Tskhay, et al.
Published: (2023-04-01)